Picture of Cantargia AB logo

CANTA Cantargia AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Cantargia Says Third Party Withdraws Appeal Related To Cantargia Patent

May 16 (Reuters) - Cantargia AB  CANTA.ST :
    * THIRD PARTY WITHDRAWS APPEAL RELATED TO CANTARGIA PATENT
    * NOTICE OF APPEAL FILED WITH RESPECT TO ONE OF CANTARGIA'S
GRANTED EUROPEAN PATENTS, EP3020730, HAS BEEN WITHDRAWN.
    * PATENT REMAINS IN FORCE WITH CLAIMS ENCOMPASSING TREATMENT
OF
SOLID TUMOURS BY ANTI-IL1RAP-TARGETING ANTIBODY

Source text for Eikon:  ID:nMFN2tbfmH 
Further company coverage:  CANTA.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Cantargia AB

See all news